Acquired hemophilia A following SARS CoV-2 mRNA vaccine: Correspondence. | J Oncol Pharm Pract;28(6): 1434, 2022 09. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Acquired hemophilia A following SARS CoV-2 mRNA vaccine: Correspondence.

Sookaromdee, Pathum; Wiwanitkit, Viroj.

Sookaromdee P; Private Academic Consultant, Bangkok, Thailand.
Wiwanitkit V; Dr DY Patil University, Pune, India.

J Oncol Pharm Pract ; 28(6): 1434, 2022 09.

Article in English | MEDLINE | ID: covidwho-1820080

Subject(s)

COVID-19; Hemophilia A; Severe Acute Respiratory Syndrome; COVID-19/prevention & control; Hemophilia A/drug therapy; Humans; Vaccines, Synthetic; mRNA Vaccines

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severe Acute Respiratory Syndrome / COVID-19 / Hemophilia A Topics: Vaccines Limits: Humans Language: English Journal: J Oncol Pharm Pract Journal subject: Pharmacy Year: 2022 Document Type: Article Affiliation country: 10781552221082575

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severe Acute Respiratory Syndrome / COVID-19 / Hemophilia A Topics: Vaccines Limits: Humans Language: English Journal: J Oncol Pharm Pract Journal subject: Pharmacy Year: 2022 Document Type: Article Affiliation country: 10781552221082575